全文获取类型
收费全文 | 4723篇 |
免费 | 362篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 161篇 |
妇产科学 | 120篇 |
基础医学 | 558篇 |
口腔科学 | 109篇 |
临床医学 | 404篇 |
内科学 | 918篇 |
皮肤病学 | 97篇 |
神经病学 | 393篇 |
特种医学 | 247篇 |
外科学 | 476篇 |
综合类 | 734篇 |
一般理论 | 3篇 |
预防医学 | 413篇 |
眼科学 | 36篇 |
药学 | 195篇 |
中国医学 | 3篇 |
肿瘤学 | 243篇 |
出版年
2021年 | 44篇 |
2020年 | 36篇 |
2019年 | 50篇 |
2018年 | 58篇 |
2017年 | 44篇 |
2016年 | 47篇 |
2015年 | 51篇 |
2014年 | 103篇 |
2013年 | 153篇 |
2012年 | 128篇 |
2011年 | 159篇 |
2010年 | 121篇 |
2009年 | 113篇 |
2008年 | 219篇 |
2007年 | 256篇 |
2006年 | 285篇 |
2005年 | 249篇 |
2004年 | 253篇 |
2003年 | 229篇 |
2002年 | 127篇 |
2001年 | 124篇 |
2000年 | 134篇 |
1999年 | 142篇 |
1998年 | 98篇 |
1997年 | 98篇 |
1996年 | 74篇 |
1995年 | 59篇 |
1994年 | 57篇 |
1993年 | 53篇 |
1992年 | 84篇 |
1991年 | 85篇 |
1990年 | 69篇 |
1989年 | 98篇 |
1988年 | 77篇 |
1987年 | 91篇 |
1986年 | 68篇 |
1985年 | 64篇 |
1984年 | 71篇 |
1983年 | 47篇 |
1981年 | 34篇 |
1980年 | 39篇 |
1979年 | 59篇 |
1977年 | 38篇 |
1975年 | 37篇 |
1974年 | 38篇 |
1973年 | 58篇 |
1972年 | 43篇 |
1971年 | 39篇 |
1970年 | 36篇 |
1968年 | 42篇 |
排序方式: 共有5135条查询结果,搜索用时 31 毫秒
41.
Based on a telephone interview and medical record review of the urological outcomes among 40 spinal cord injury patients with a neuropathic bladder at discharge who were an average of 60 months post-injury and who were all initially managed by chronic clean intermittent catheterisation (CCIC), the following conclusions were made: Over 80% of patients using CCIC at discharge continued to use it, suggesting low morbidity and high patient acceptance; Urological complications in patients using CCIC were more frequent in the lower urinary tract than in the upper urinary tract, were more frequent in men than women, and had a low morbidity; Urological complications and hospitalisations were more frequent among the 41% of patients using CCIC who had frequent SxUTIs; SxUTIs were common in patients using CCIC but rates may be comparable with other methods; Although 44% of CCIC patients were hospitalised at least once in 5 years for urological complications, this is comparable to reported multi-centre outcomes in the U.S.A. (Young, 1982). 相似文献
42.
43.
44.
Cutaneous T-cell lymphoma 总被引:1,自引:0,他引:1
45.
Jonathan Larkin Ling Jin Mark Farmen Daryl Venable Ying Huang Seng-Lai Tan John I Glass 《Journal of interferon & cytokine research》2003,23(5):247-257
The use of type I interferon (IFN), in combination with ribvirin, to treat chronic hepatitis C virus (HCV) infection has many drawbacks that prevent widespread application, ultimately leading to a significant unmet clinical need. Potential improvements in IFN therapy through targeted delivery, molecular alteration, and combination with other agents are ongoing in an attempt to decrease adverse effects and increase efficacy. In this report, the HCV replicon cell culture system was used to assess potential synergistic antiviral effects of multiple IFN species when administered in combination. Quantitative analysis of HCV replicon RNA by TaqMan (PE Applied Biosystems, Foster City, CA) and qualitative analysis of HCV protein expression were used to measure the antiviral efficacy of individual and combination IFN treatments, and synergistic responses of IFN combinations were determined through statistical analysis of the TaqMan results. We found that when administered simultaneously, type I/II IFN combinations (IFN-alpha2b + IFN-gamma or IFN-beta + IFN-gamma) resulted in dramatic antiviral synergy, whereas a type I/I combination (IFN-alpha2b + IFN-beta) demonstrated a slightly antagonistic profile. The synergistic effect is likely due to differential cell surface receptors and signaling pathways employed by types I and II IFNs. Conversely, all type I IFN species bind the same receptor and signal through similar pathways, possibly accounting for the nearly additive response observed. In support of this hypothesis, IFN treatment resulted in differential induction of Stat1 phosphorylation at Tyr 701. In conclusion, simultaneous type I/II IFN combination treatment may allow an overall decreased effective IFN dose, which may reduce the side effect profiles that hinder current therapy. 相似文献
46.
Lymphocyte transformation to 1-24ACTH, as assessed by the incorporation of tritiated thymidine, has been demonstrated to be associated with severe adverse reactions occurring in patients receiving a Zn-linked 1-24ACTH preparation (Tetra cosactrin depot, 'Synacthen'). Antibodies measured with an isotope-binding assay occurred commonly in all patients receiving therapy and did not correlate with adverse reactions. Lymphocyte transformation with the 1-24ACTH polypeptide, a part of the naturally occurring ACTH molecule, has not been previously recorded. The significance of antibodies and cell-mediated immunity to this polypeptide hormone is discussed. 相似文献
47.
48.
Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season
下载免费PDF全文
![点击此处可从《Journal of clinical microbiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Clark HF Lawley DA Schaffer A Patacsil JM Marcello AE Glass RI Jain V Gentsch J 《Journal of clinical microbiology》2004,42(4):1434-1438
Rotavirus causes severe morbidity in developed countries and frequent deaths (> or = 500,000 per year) in less-developed countries. Historically, four serotypes--G1, G2, G3, and G4-have predominated; they are distinguished by one of two surface neutralization antigens (VP7). However, in 1983 and 1984 we described a new rotavirus serotype, designated G9, in five children hospitalized for diarrhea in Philadelphia, Pa. G9 rotavirus was not identified again in the Western Hemisphere until it caused ca. 50% of the rotavirus disease detected in Philadelphia in the 1995-1996 season. This outbreak allowed us to question whether a rotavirus strain completely new to a well-studied community would target either very young infants or older children, cause especially severe disease, or completely displace previously extant serotypes. We observed a significant excess of G9 infections in younger infants (especially in those < 6 months old) that might be attributed to the lack of G9-specific antibodies in mothers. Of further note, six of the seven oldest patients with rotavirus diarrhea were infected with the G9 strains (not significant). However, the age distribution of children with rotavirus did not differ over a 5-year study period regardless of the infecting serotype. Patients with diarrhea associated with G9 strains did not have disease more severe than that caused by the G1, G2, or G3 serotype. G9 strains did not displace the other serotypes but were virtually completely replaced by G1 or G2 serotypes in the three subsequent rotavirus seasons. We conclude that the abrupt appearance of this novel rotavirus serotype did not present a special threat to public health in the community. 相似文献
49.
Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. 总被引:5,自引:3,他引:5
下载免费PDF全文
![点击此处可从《Journal of clinical microbiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
J U Cope A Hildesheim M H Schiffman M M Manos A T Lrincz R D Burk A G Glass C Greer J Buckland K Helgesen D R Scott M E Sherman R J Kurman K L Liaw 《Journal of clinical microbiology》1997,35(9):2262-2265
The strong association of human papillomavirus (HPV) and cervical cancer makes it important to study HPV detection methods that may play a role in cervical cancer screening. We compared two DNA methods that are commonly used for HPV research in the United States: the MY09/MY11 L1 consensus primer PCR-based test and the first-generation Hybrid Capture tube method (HCT). Laboratory assays by each method were performed with 596 cervicovaginal specimens collected from participants in a large cohort study conducted in Portland, Oreg. Included were 499 specimens from women whose cytology was normal and 97 specimens from women with squamous intraepithelial lesions (SILs). The overall HPV DNA positivity for known types was 22.5% by PCR compared to 13.6% by HCT. When the analysis was restricted to the 14 HPV types detectable by both methods, the sensitivity of HCT, with PCR used as the standard for HPV status, was higher for specimens from women with concurrent SILs (81.0%) than for specimens from women with normal cytology (46.7%). Among specimens testing positive by both methods, 97.2% of the time the two methods agreed on whether specimens were positive for cancer-associated HPV types. Both of these HPV test methods provide information that supplements the information provided by the Pap smear. The PCR method has higher analytic sensitivity than HCT in detecting HPV, but HCT may be helpful in identifying women with concurrent SILs. 相似文献
50.
J L Cromien C A Himmelreich R I Glass G A Storch 《Journal of clinical microbiology》1987,25(12):2359-2362
We evaluated a new commercial enzyme immunoassay (EIA) for rotavirus (Rotavirus EIA; International Diagnostic Laboratories, Chesterfield, Mo.). A total of 161 consecutive stool samples (including 18 from infants less than 30 days old) submitted to the diagnostic laboratory at Children's Hospital, Washington University Medical Center, St. Louis, Mo., for rotavirus detection were tested by Rotavirus EIA and by Rotazyme II (Abbott Laboratories, North Chicago, III.) according to the instructions of the manufacturer. In addition, 16 samples from infants less than 30 days old without diarrhea were tested by both assays. Samples showing discrepant results after repeat testing were examined by electron microscopy. Nine samples yielding discrepant results were also tested by using a reference EIA directly on the specimen and on culture supernatants from two passages in MA 104 cells. Rotavirus EIA and Rotazyme II yielded concordant results for 85% of the samples. All of the 26 discrepant samples tested negative by Rotavirus EIA and positive (15 samples) or equivocal (11 samples) by Rotazyme II. These samples included 11 from symptomatic infants more than 30 days old, 2 from symptomatic infants less than 30 days old (neonates), and 2 from neonates without diarrhea. Rotavirus was not detected in any of the 24 that were examined by electron microscopy or in any of the 9 that were tested by the reference EIA. The sensitivity, specificity, positive predictive value, and negative predictive value were 100% for Rotazyme EIA and 100, 90, 70, and 100%, respectively, for Rotazyme II. Rotavirus EIA was comparable to Rotazyme II in ease of performance. We conclude that Rotavirus EIA is equally sensitive and more specific than Rotazyme II for detecting rotavirus. Rotavirus EIA is a practical and accurate rotavirus assay for use in clinical laboratories. 相似文献